Intravenous natural beta interferon treatment of chronic exacerbating-remitting multiple sclerosis: clinical response and MRI/CSF findings
- PMID: 3367166
- DOI: 10.1007/BF00314311
Intravenous natural beta interferon treatment of chronic exacerbating-remitting multiple sclerosis: clinical response and MRI/CSF findings
Abstract
A preliminary study is reported of clinical response and CSF/MRI findings in nine patients with multiple sclerosis receiving intravenous infusions of natural beta-interferon. The mean patient follow-up was for 1.2 years. Neither exacerbation rates nor CSF-IgG synthesis nor plaque formation as revealed by MRI showed a significant reduction during therapy. One patient developed a severe exacerbation of multiple sclerosis shortly after interferon infusion.
Similar articles
-
Intrathecally administered natural human fibroblast interferon reduces exacerbations of multiple sclerosis. Results of a multicenter, double-blind study.Arch Neurol. 1987 Jun;44(6):589-95. doi: 10.1001/archneur.1987.00520180013008. Arch Neurol. 1987. PMID: 3579676 Clinical Trial.
-
Multicentre double-blind study of effect of intrathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosis.Lancet. 1986 Dec 20-27;2(8521-22):1411-3. doi: 10.1016/s0140-6736(86)92730-3. Lancet. 1986. PMID: 2878272 Free PMC article. Clinical Trial.
-
Oligoclonal "fingerprint" of CSF IgG in multiple sclerosis patients is not modified following intrathecal administration of natural beta-interferon.J Neurol Neurosurg Psychiatry. 1986 Nov;49(11):1308-12. doi: 10.1136/jnnp.49.11.1308. J Neurol Neurosurg Psychiatry. 1986. PMID: 3794738 Free PMC article.
-
[Treatment of multiple sclerosis with interferons].Rev Med Chil. 1996 May;124(5):597-604. Rev Med Chil. 1996. PMID: 9035514 Review. Spanish.
-
Mitoxantrone: a review of its use in multiple sclerosis.CNS Drugs. 2004;18(6):379-96. doi: 10.2165/00023210-200418060-00010. CNS Drugs. 2004. PMID: 15089110 Review.
Cited by
-
Prescribing recommendations for interferon-Beta in multiple sclerosis.CNS Drugs. 1997 Aug;8(2):102-12. doi: 10.2165/00023210-199708020-00002. CNS Drugs. 1997. PMID: 23338215
-
Double blind study of intrathecal beta-interferon in multiple sclerosis: clinical and laboratory results.J Neurol Neurosurg Psychiatry. 1990 Jul;53(7):554-7. doi: 10.1136/jnnp.53.7.554. J Neurol Neurosurg Psychiatry. 1990. PMID: 1697334 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical